{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:07:10Z","timestamp":1789726030875,"version":"4.0.1"},"reference-count":159,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bbcan.2014.08.006","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T16:09:28Z","timestamp":1410019768000},"page":"457-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications"],"prefix":"10.1016","volume":"1846","author":[{"given":"Tomasz","family":"Sewastianik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Prochorec-Sobieszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Chapuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Juszczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2014.08.006_bb0005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/JVI.31.2.514-521.1979","article-title":"DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus","volume":"31","author":"Sheiness","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1146\/annurev.ge.18.120184.003005","article-title":"The molecular genetics of cellular oncogenes","volume":"18","author":"Varmus","year":"1984","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0015","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0020","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","article-title":"Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells","volume":"79","author":"Taub","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0030","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","article-title":"Burkitt lymphoma in the mouse","volume":"192","author":"Kovalchuk","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0035","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1101\/gad.1024602","article-title":"c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression","volume":"16","author":"Baudino","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0040","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.313104","article-title":"c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation","volume":"18","author":"Wilson","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0045","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.exphem.2007.05.015","article-title":"c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin(\u2212)Sca-1(+)c-Kit(\u2212) cell generation through p21","volume":"35","author":"Baena","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/eji.200737972","article-title":"Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse","volume":"38","author":"Huang","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0055","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ni.2428","article-title":"The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry","volume":"13","author":"Dominguez-Sola","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0060","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.276.5312.596","article-title":"Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation","volume":"276","author":"Lin","year":"1997","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ni.2418","article-title":"The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers","volume":"13","author":"Calado","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0070","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","article-title":"AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations","volume":"135","author":"Robbiani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cell.2004.08.006","article-title":"AID is required for c-myc\/IgH chromosome translocations in vivo","volume":"118","author":"Ramiro","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12308-009-0038-8","article-title":"Commentary on the WHO classification of tumors of lymphoid tissues (2008): aggressive B-cell lymphomas","volume":"2","author":"Balague Ponz","year":"2009","journal-title":"J. Hematop."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0085","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"262","article-title":"Burkitt lymphoma","author":"Leoncini","year":"2008"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0090","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00000478-200006000-00010","article-title":"CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas","volume":"24","author":"Dogan","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund UK"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0100","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1073\/pnas.85.8.2748","article-title":"Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma","volume":"85","author":"Neri","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/MCB.9.1.74","article-title":"Somatic mutation and transcriptional deregulation of myc in endemic Burkitt's lymphoma disease: heptamer-nonamer recognition mistakes?","volume":"9","author":"Morse","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/path.2807","article-title":"The molecular background of aggressive B cell lymphomas as a basis for targeted therapy","volume":"223","author":"de Jong","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/path.2410","article-title":"MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation","volume":"216","author":"Leucci","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012960","article-title":"Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma","volume":"5","author":"Onnis","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0125","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0130","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3960\/jslrt.51.7","article-title":"BCL2 and MYC dual-hit lymphoma\/leukemia","volume":"51","author":"Tomita","year":"2011","journal-title":"J. clin. exp. Hematopathology: JCEH"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ccr.2012.07.014","article-title":"Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma","volume":"22","author":"Monti","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3324\/haematol.2009.012864","article-title":"Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma","volume":"95","author":"Stasik","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0150","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"Mechanisms in Malignant Lymphomas Network Project of the Deutsche, a biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0155","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0160","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0165","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0170","doi-asserted-by":"crossref","first-page":"e33813","DOI":"10.1371\/journal.pone.0033813","article-title":"Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas","volume":"7","author":"Kluk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0175","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0180","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3324\/haematol.2013.086173","article-title":"MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"98","author":"Valera","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0185","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1097\/01.pas.0000180442.87022.08","article-title":"Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior","volume":"29","author":"McClure","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0190","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","article-title":"Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma","volume":"29","author":"Haralambieva","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0195","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"265","article-title":"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma","author":"Kluin","year":"2008"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0200","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","volume":"22","author":"Klapper","year":"2008","journal-title":"Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund UK"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0205","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0210","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0215","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":"Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Green","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0220","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0225","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/1947601910377495","article-title":"Myc roles in hematopoiesis and leukemia","volume":"1","author":"Delgado","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0230","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0235","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bcmd.2010.08.002","article-title":"The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma","volume":"45","author":"Smith","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0240","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.2006410","article-title":"Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc","volume":"251","author":"Blackwood","year":"1991","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0245","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1073\/pnas.81.22.7046","article-title":"Extreme instability of myc mRNA in normal and transformed human cells","volume":"81","author":"Dani","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0250","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/MCB.4.11.2486","article-title":"Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells","volume":"4","author":"Hann","year":"1984","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0255","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ncb1110","article-title":"A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells","volume":"6","author":"Yeh","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0260","doi-asserted-by":"crossref","first-page":"51606","DOI":"10.1074\/jbc.M310722200","article-title":"Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization","volume":"278","author":"Gregory","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0265","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1038\/onc.2008.123","article-title":"Pim kinase-dependent inhibition of c-Myc degradation","volume":"27","author":"Zhang","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0270","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/sj.onc.1206800","article-title":"c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis","volume":"22","author":"Kanazawa","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0275","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.embor.embor821","article-title":"Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP","volume":"4","author":"Vervoorts","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0280","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1101\/gad.906601","article-title":"Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation","volume":"15","author":"Frank","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0285","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1097-2765(00)80427-X","article-title":"An ATPase\/helicase complex is an essential cofactor for oncogenic transformation by c-Myc","volume":"5","author":"Wood","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0290","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0092-8674(01)00450-0","article-title":"The p400 complex is an essential E1A transformation target","volume":"106","author":"Fuchs","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0295","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1097-2765(03)00193-X","article-title":"The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription","volume":"11","author":"von der Lehr","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0300","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/35070076","article-title":"Repression of p15INK4b expression by Myc through association with Miz-1","volume":"3","author":"Staller","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0305","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7600509","article-title":"Myc represses transcription through recruitment of DNA methyltransferase corepressor","volume":"24","author":"Brenner","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0310","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1002\/j.1460-2075.1995.tb00252.x","article-title":"Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation","volume":"14","author":"Hurlin","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1101\/gad.11.1.44","article-title":"Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites","volume":"11","author":"Hurlin","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0320","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0092-8674(00)80214-7","article-title":"Histone deacetylase activity is required for full transcriptional repression by mSin3A","volume":"89","author":"Hassig","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0325","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1038\/sj.onc.1203639","article-title":"A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts","volume":"19","author":"Berns","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0330","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1128\/MCB.22.16.5793-5800.2002","article-title":"A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism","volume":"22","author":"Nikiforov","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0335","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2006.00373.x","article-title":"A library of gene expression signatures to illuminate normal and pathological lymphoid biology","volume":"210","author":"Shaffer","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0340","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1073\/pnas.0806445106","article-title":"ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes","volume":"106","author":"Margolin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0345","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","article-title":"An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors","volume":"40","author":"Ben-Porath","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0350","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","article-title":"Myc-driven murine prostate cancer shares molecular features with human prostate tumors","volume":"4","author":"Ellwood-Yen","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0355","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrm1703","article-title":"Transcriptional regulation and transformation by Myc proteins","volume":"6","author":"Adhikary","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0360","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrc1393","article-title":"Analysis of genomic targets reveals complex functions of MYC","volume":"4","author":"Patel","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0365","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","article-title":"c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells","volume":"151","author":"Nie","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0370","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated c-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0375","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cell.2010.03.030","article-title":"c-Myc regulates transcriptional pause release","volume":"141","author":"Rahl","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0380","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/1947601910379012","article-title":"Transcriptional repression: the dark side of myc","volume":"1","author":"Herkert","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0385","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1002\/j.1460-2075.1995.tb00163.x","article-title":"Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes","volume":"14","author":"Steiner","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0390","first-page":"103","article-title":"Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins","volume":"1287","author":"Beijersbergen","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0395","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood-2009-11-251074","article-title":"Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state","volume":"116","author":"den Hollander","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0400","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1073\/pnas.082005599","article-title":"Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes","volume":"99","author":"Menssen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0405","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0410","doi-asserted-by":"crossref","first-page":"21797","DOI":"10.1074\/jbc.C000023200","article-title":"Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc","volume":"275","author":"Osthus","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0415","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","article-title":"Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells","volume":"15","author":"Le","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0420","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ccr.2007.07.006","article-title":"HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation","volume":"12","author":"Gordan","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0425","doi-asserted-by":"crossref","first-page":"12563","DOI":"10.1074\/jbc.M210462200","article-title":"A large scale genetic analysis of c-Myc-regulated gene expression patterns","volume":"278","author":"O'Connell","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0430","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia","volume":"101","author":"Egle","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0435","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1101\/gad.12.15.2424","article-title":"Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization","volume":"12","author":"Zindy","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0440","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0450","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0455","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis","volume":"40","author":"Chang","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0465","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ccr.2012.09.003","article-title":"Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-cell lymphomas","volume":"22","author":"Zhang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0470","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/onc.2011.470","article-title":"Myc represses miR-15a\/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0475","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","article-title":"MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells","volume":"67","author":"Sampson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0480","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1073\/pnas.0808300106","article-title":"Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation","volume":"106","author":"Chang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0485","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/1947601910377491","article-title":"Myc: Maestro of MicroRNAs","volume":"1","author":"Bui","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0490","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.compbiomed.2013.06.002","article-title":"Identification and analysis of the regulatory network of Myc and microRNAs from high-throughput experimental data","volume":"43","author":"Xiong","year":"2013","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0495","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0500","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1073\/pnas.0403286101","article-title":"Suppression of tumorigenesis by the p53 target PUMA","volume":"101","author":"Hemann","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0505","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","article-title":"p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa","volume":"302","author":"Villunger","year":"2003","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0510","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/cdd.2008.195","article-title":"Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis","volume":"16","author":"Michalak","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0515","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1128\/MCB.21.22.7653-7662.2001","article-title":"Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis","volume":"21","author":"Eischen","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0520","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells","volume":"335","author":"Vaux","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0525","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/359552a0","article-title":"Apoptotic cell death induced by c-myc is inhibited by bcl-2","volume":"359","author":"Bissonnette","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0530","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","article-title":"p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia","volume":"88","author":"Gaidano","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0535","first-page":"4273","article-title":"The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors","volume":"52","author":"Bhatia","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0540","doi-asserted-by":"crossref","first-page":"17961","DOI":"10.1073\/pnas.0809957105","article-title":"In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas","volume":"105","author":"Mason","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0545","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"van Delft","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0550","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1101\/gad.232009.113","article-title":"Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53","volume":"28","author":"Kelly","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0555","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"Srinivasan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0560","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0565","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/MCB.00650-10","article-title":"Cyclin D3 is selectively required for proliferative expansion of germinal center B cells","volume":"31","author":"Cato","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0570","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/cr.2010.55","article-title":"Requirement for cyclin D3 in germinal center formation and function","volume":"20","author":"Peled","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0575","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1101\/gad.1105003","article-title":"The serine\/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor","volume":"17","author":"Fox","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0580","doi-asserted-by":"crossref","first-page":"448","DOI":"10.18632\/oncotarget.283","article-title":"The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas","volume":"2","author":"Forshell","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0585","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/MCB.11.2.1176","article-title":"Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally","volume":"11","author":"Verbeek","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0590","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood-2009-07-233445","article-title":"A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia\/lymphoma","volume":"115","author":"Lin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0595","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.onc.1201288","article-title":"Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc","volume":"15","author":"Allen","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0600","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature07260","article-title":"Modelling Myc inhibition as a cancer therapy","volume":"455","author":"Soucek","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0605","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1073\/pnas.1107303108","article-title":"Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0610","doi-asserted-by":"crossref","first-page":"e22284","DOI":"10.1371\/journal.pone.0022284","article-title":"The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy","volume":"6","author":"Savino","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0615","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.onc.1202199","article-title":"Design and properties of a Myc derivative that efficiently homodimerizes","volume":"17","author":"Soucek","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0620","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00280-008-0774-y","article-title":"Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058\u2013F4 [Z, E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice","volume":"63","author":"Guo","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0625","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1947601910377494","article-title":"Therapeutic targeting of Myc","volume":"1","author":"Prochownik","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0630","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0635","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2012-02-413021","article-title":"BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia","volume":"120","author":"Ott","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0640","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrc3256","article-title":"BET domain co-regulators in obesity, inflammation and cancer","volume":"12","author":"Belkina","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0645","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","article-title":"Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma","volume":"24","author":"Chapuy","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0650","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0655","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master transcription factors and mediator establish super-enhancers at key cell identity genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0660","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0665","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0670","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0675","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0680","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0685","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0690","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2009-03-212852","article-title":"Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0695","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2010-12-323022","article-title":"Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia","volume":"118","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0700","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1128\/MCB.24.13.6104-6115.2004","article-title":"Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors","volume":"24","author":"Mikkers","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0705","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis","volume":"104","author":"Nguyen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0710","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1158\/1541-7786.MCR-11-0394","article-title":"Phosphoinositide 3-kinase\/AKT\/mTORC1\/2 signaling determines sensitivity of Burkitt's lymphoma cells to BH3 mimetics","volume":"10","author":"Spender","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0715","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1535-7163.1427.3.11","article-title":"Specific inhibition of cyclin-dependent kinase 4\/6 by PD 0332991 and associated antitumor activity in human tumor xenografts","volume":"3","author":"Fry","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0720","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1200\/JCO.2012.46.8793","article-title":"Phase II study of alisertib, a selective aurora a kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas","volume":"32","author":"Friedberg","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0725","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0730","first-page":"617","article-title":"Regulation of intracellular pH in human melanoma: potential therapeutic implications","volume":"1","author":"Wahl","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0735","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","article-title":"A mitochondria-K+channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth","volume":"11","author":"Bonnet","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0740","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/bjc.2012.527","article-title":"PDK1 inhibition is a novel therapeutic target in multiple myeloma","volume":"108","author":"Fujiwara","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0745","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccr.2012.09.021","article-title":"ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation","volume":"22","author":"Qing","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0750","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/leu.2008.344","article-title":"Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC translocations","volume":"23","author":"Niitsu","year":"2009","journal-title":"Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund UK"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0755","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2404529","article-title":"Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas","volume":"21","author":"Bertrand","year":"2007","journal-title":"Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund UK"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0760","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood.V98.10.3082","article-title":"Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors","volume":"98","author":"Avet-Loiseau","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0765","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.97.1.228","article-title":"Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma","volume":"97","author":"Shou","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0770","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/cncr.24862","article-title":"Adult acute lymphoblastic leukemia: concepts and strategies","volume":"116","author":"Faderl","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2014.08.006_bb0775","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM198805263182106","article-title":"Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma","volume":"318","author":"De Jong","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0780","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1309\/NKK3FEX2BE5L7EKB","article-title":"Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event","volume":"129","author":"Young","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0785","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/PAP.0b013e3182169948","article-title":"MYC and aggressive B-cell lymphomas","volume":"18","author":"Slack","year":"2011","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0790","first-page":"155","article-title":"Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature","volume":"6","author":"Setoodeh","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbcan.2014.08.006_bb0795","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-011-1393-y","article-title":"Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course","volume":"91","author":"Put","year":"2012","journal-title":"Ann. Hematol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X14000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X14000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T12:19:03Z","timestamp":1689509943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X14000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":159,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0304419X14000808"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2014.08.006","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2014.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}